Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Lakewood-Amedex Biotherapeutics Inc. (LABT) had Weighted-Average Shares Outstanding (Diluted) of 0.70M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-5.85M |
|
-- |
|
-- |
|
3.77M |
|
-3.77M |
|
-0.08M |
|
-3.85M |
|
-3.85M |
|
-3.85M |
|
-3.85M |
|
-3.85M |
|
-3.85M |
|
-3.77M |
|
-3.65M |
|
0.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.70M |
-8.40 |
|
-8.40 |
|
| Balance Sheet Financials | |
0.31M |
|
0.01M |
|
0.18M |
|
0.48M |
|
2.41M |
|
-- |
|
0.04M |
|
2.45M |
|
-1.97M |
|
-1.96M |
|
-1.96M |
|
0.70M |
|
| Cash Flow Statement Financials | |
-1.94M |
|
-- |
|
1.50M |
|
0.68M |
|
0.24M |
|
-0.44M |
|
1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-- |
|
-0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
195.55% |
|
195.85% |
|
-798.93% |
|
195.85% |
|
-2.81 |
|
-2.79 |
|
-2.79 |
|